Prospective Study
Copyright ©The Author(s) 2025.
World J Cardiol. Apr 26, 2025; 17(4): 106072
Published online Apr 26, 2025. doi: 10.4330/wjc.v17.i4.106072
Table 2 Variables collected and assessed in each patient enrolled in the ULTRA-STEMI trial
Data
Pre-intervention
Post-intervention
Post-optimization
IVUS dataVessel, lumen and plaque cross-sectional area; Minimal lumen area; Plaque area and burden; Calcium severity; Supposed thrombus presence; Thrombus morphology (acute, subacute, organized)Stent expansion; Plaque burden at stent edges; Edge dissection; Haematoma; Malapposition; Thrombus protrusion through stent struts; Percentage area stenosisMinimum stent area; Stent underexpansion; Stent malapposition; Stent deformation; Stent edge dissection; Residual disease at stent edge
Pre-PCIPost-PCI
Echocardiographic dataLVEFLVEF
Clinical dataMedical history; electrocardiographic and laboratory data; IIb/IIIa inhibitors/heparin administrationElectrocardiographic and laboratory data;
Stent length and diameter; Amount of contrast drug administered; PCI and CA duration; Total effective radiation dose; Total fluoroscopy time; Number and type of stents; Number of catheters used; ST-segment resolution
Micro-CT dataThrombus volume
n.a.Thrombus density
Angiographic dataPre-procedural TIMI flow; Thrombus burden classification; Culprit vessel; Number of diseased vessels; SYNTAX scoreAngiographically evident residual thrombus burden; Myocardial no-reflow phenomenon; Post-procedural TIMI flow; Distal embolization
Follow-up datan.a.Mortality (+cause); CV-hospitalization; MI/revascularization(+vessel); Thromboembolic or bleeding event; Peri- and post-procedural complications